• Hans-Christian Hansen, Christine Klingbeil, Josep Dalmau, Wenhan Li, Benedikt Weissbrich, and Klaus-Peter Wandinger.
• Department of Neurology and Psychiatry, Friedrich-Ebert-Hospital, Neumünster, Germany.
• JAMA Neurol. 2013 Jan 1;70(1):117-9.

BackgroundAnti- N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune disorder characterized by high intrathecal antibody synthesis. Little is known about the long-term follow-up of the cerebrospinal fluid antibody status.ObjectiveTo describe persistent intrathecal antibody synthesis in a clinically healthy person 15 years after recovering from anti-NMDAR encephalitis.DesignCase report.SettingAcademic medical center.PatientA 40-year-old woman who had been diagnosed as having encephalitis of unknown origin in 1995.Main Outcome MeasuresClinical evaluation and NMDAR antibody testing.ResultsOn reexamination in 2011, the patient had fully recovered. Investigation of archived as well as follow-up serum and cerebrospinal fluid samples revealed intrathecal synthesis of NMDAR antibodies.ConclusionsThis is the longest follow-up on a patient with anti-NMDAR encephalitis. Our findings emphasize that intrathecal antibody synthesis does not necessarily reflect disease activity and that the significance of NMDAR antibody titers needs to be interpreted for each patient according to the clinical context.

12 keywords...

hide…